Drotrecogin alfa (activated): real-life use and outcomes for the UK
-
* Corresponding author: Kathryn M Rowan kathy.rowan@icnarc.org
Critical Care 2008, 12:R58 doi:10.1186/cc6879
Accesses
- Last 30 days: 27 accesses
- Last 365 days: 478 accesses
- All time: 4542 accesses